上海医药(601607)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

601607 上海医药

午间休市 08-16 11:29:47

{"stockData":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":19.6,"timestamp":1723778987000,"preClose":19.61,"halted":0,"volume":2792354,"delay":0,"floatShares":1932000000,"shares":3704000000,"eps":1.024,"marketStatus":"午间休市","marketStatusCode":3,"change":-0.01,"latestTime":"08-16 11:29:47","open":19.6,"high":19.69,"low":19.52,"amount":54750500,"amplitude":0.0087,"askPrice":19.6,"askSize":5,"bidPrice":19.59,"bidSize":9,"shortable":0,"etf":0,"ttmEps":1.024,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1723784400000},"adr":0,"adjPreClose":19.61,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":21.57,"lowLimit":17.65,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3704079999,"pbRate":1.04,"roa":"--","roe":"2.23%","epsLYR":1.02,"committee":-0.461088,"marketValue":72600000000,"floatMarketCap":37873000000,"peRate":19.140624,"changeRate":-0.0005,"turnoverRate":0.0014,"status":1},"requestUrl":"/m/hq/s/601607/wiki","defaultTab":"wiki","newsList":[{"id":"2459114857","title":"上海医药08月14日主力资金流入2650万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2459114857","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459114857?lang=zh_cn&edition=full","pubTime":"2024-08-14 15:19","pubTimestamp":1723619967,"startTime":"0","endTime":"0","summary":"08月14日, 上海医药股价跌0.15%，报收19.42元，成交金额1.21亿元，换手率0.32%，振幅1.70%，量比0.72。上海医药今日主力资金净流入2650万元，连续5日净流入，上一交易日主力净流入951万元，今日环比增加178.65%。该股近5个交易日上涨0.99%，主力资金累计净流入8969万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入7226万元，其中净流入天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814153342959789d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814153342959789d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0097","BK0012","BK0184","BK0020","BK0028","BK0099","BK0187","BK0188","BK0196","BK0183","BK0209","601607","BK0175"],"gpt_icon":0},{"id":"2458541673","title":"上海医药08月12日主力资金流入2259万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2458541673","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458541673?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:18","pubTimestamp":1723447132,"startTime":"0","endTime":"0","summary":"08月12日, 上海医药股价涨1.95%，报收19.37元，成交金额2.06亿元，换手率0.55%，振幅2.63%，量比1.05。上海医药今日主力资金净流入2259万元，连续3日净流入，上一交易日主力净流入1309万元，今日环比增加72.57%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为0.81%。该股近5个交易日上涨2.05%，主力资金累计净流入6569万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入6801万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408121529059f23aa3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408121529059f23aa3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0187","BK0012","BK0028","601607","BK0020","BK0184","BK0209","BK0097","BK0188","BK0183","BK0196","BK0175","BK0099"],"gpt_icon":0},{"id":"2457333660","title":"南宁百货创2月新高 上海医药携手打造生物医药创新平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2457333660","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457333660?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:54","pubTimestamp":1723085640,"startTime":"0","endTime":"0","summary":"消息解读7月18日，上海市政府印发实施了《关于支持生物医药产业全链条创新发展的若干意见》，推出8方面37条政策举措，全力推进生物医药产业全链条创新发展。上海医药携手一流高校及顶尖科研机构发布“上海前沿”品牌。“上海前沿”位于国家级生物医药基地张江科学城的核心区域，拥有超过12万平方米的科创空间、模块化实验室和高端科研设备，旨在为中国及全球生物医药创新者提供一个充满活力的开放合作平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808105542aefdd60d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808105542aefdd60d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0099","BK0086","BK0020","BK0063","399441","BK0209","BK0187","600712","BK0183","BK0188","BK0196","BK0107","BK0097","161726","601607","BK0028","BK0184","BK0175"],"gpt_icon":0},{"id":"2457185451","title":"中邮证券：给予上海医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2457185451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457185451?lang=zh_cn&edition=full","pubTime":"2024-08-07 12:01","pubTimestamp":1723003271,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,龙永茂近期对上海医药进行研究并发布了研究报告《商一体化龙头企业，整装待发迎边际催化》，本报告对上海医药给出买入评级，当前股价为19.19元。2010年，上海医药于A股上市，次年于港股上市。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为23.3。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700024285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607","161027"],"gpt_icon":0},{"id":"2457401341","title":"上海医药(02607.HK)塞来昔布胶囊获批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2457401341","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457401341?lang=zh_cn&edition=full","pubTime":"2024-08-06 17:37","pubTimestamp":1722937020,"startTime":"0","endTime":"0","summary":"上海医药(02607.HK) 公布，控股子公司常州制药厂的塞来昔布胶囊近日收到国家药监局颁发药品注册证书，换言之该产品已获批准可生产。塞来昔布胶囊为环氧化酶-2(COX-2)特异性抑制剂，通过抑制COX-2从而抑制前列腺素的生成，是全球首款选择性非甾体抗炎镇痛药物。截至目前，集团针对该药品已投入研发费用约1,084.02万元人民币。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-06 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210429113037816_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210429113037816_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1369349/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0184","BK1197","BK0175","BK0187","BK0196","BK0209","BK0183","BK0188","601607","02607","BK0099","BK0097","BK0020","BK0028","BK0012"],"gpt_icon":0},{"id":"2457018410","title":"【上海医药(02607.HK)：塞来昔布胶囊获得批准生产】智通财经APP讯，上海医药(02607.HK)发布公告，近日，公司控股子公司常州制药厂有限公司(常州制药厂)的塞来昔布胶囊收到国家药品监督管理局颁发的《药品注册证书》(证书编号：2024S01765)，该药品获得批准生产。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457018410","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457018410?lang=zh_cn&edition=full","pubTime":"2024-08-06 17:32","pubTimestamp":1722936763,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0187","BK0175","BK0188","BK1197","BK0209","BK0184","BK0196","BK0012","BK0028","02607","BK0097","BK0020","601607","BK0183","BK0099"],"gpt_icon":0},{"id":"2457018286","title":"上海医药(02607)：塞来昔布胶囊获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2457018286","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457018286?lang=zh_cn&edition=full","pubTime":"2024-08-06 17:32","pubTimestamp":1722936763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药 发布公告，近日，公司控股子公司常州制药厂有限公司的塞来昔布胶囊收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。塞来昔布胶囊为 COX-2 特异性抑制剂，通过抑制环氧化酶-2来抑制前列腺素的生成，也是全球首款选择性非甾体抗炎镇痛药。2023年4月，常州制药厂就该药品向国家药监局提出注册上市申请，并获受理。截至本公告日，公司针对该药品已投入研发费用约人民币1084.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0187","BK0175","601607","BK0020","BK0028","BK0196","BK0099","BK0012","BK1197","BK0097","BK0184","02607","BK0183","BK0188","BK0209"],"gpt_icon":0},{"id":"2457042095","title":"上海医药称塞来昔布胶囊获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2457042095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457042095?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:49","pubTimestamp":1722930548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240806:nFWT3JT0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_zh_live","symbols":["BK0020","601607","BK0012","BK0099","BK1197","BK0028","BK0209","02607","BK0187","BK0184","BK0183","BK0175","BK0097","BK0196","BK0188"],"gpt_icon":0},{"id":"2457409379","title":"上海医药公告控股子公司常州制药厂的塞来昔布胶囊获得国家药监局批准生产。该药品为COX-2特异性抑制剂是全球首款选择性非甾体抗炎镇痛药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457409379","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457409379?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:32","pubTimestamp":1722929575,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0012","BK0097","BK0196","BK0188","BK0020","BK0028","BK0187","BK0183","BK0175","02607","BK0209","601607","BK0184","BK0099","BK1197"],"gpt_icon":0},{"id":"2457093745","title":"上海医药(601607.SH)：塞来昔布胶囊获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2457093745","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457093745?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:32","pubTimestamp":1722929554,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，公司控股子公司常州制药厂有限公司的塞来昔布胶囊收到国家药品监督管理局颁发的《药品注册证书》(证书编号：2024S01765)，该药品获得批准生产。塞来昔布胶囊为COX-2特异性抑制剂，通过抑制环氧化酶-2(COX-2)来抑制前列腺素的生成，也是全球首款选择性非甾体抗炎镇痛药(NSAIDs)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0187","BK0012","BK1197","BK0020","601607","BK0175","BK0099","BK0196","BK0097","BK0188","BK0184","BK0209","02607","BK0183"],"gpt_icon":0},{"id":"2457093014","title":"上海医药08月06日主力资金流入1374万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2457093014","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457093014?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:18","pubTimestamp":1722928692,"startTime":"0","endTime":"0","summary":"08月06日, 上海医药股价涨0.79%，报收19.13元，成交金额2.24亿元，换手率0.61%，振幅2.05%，量比0.96。上海医药今日主力资金净流入1374万元，连续3日净流入，上一交易日主力净流入1251万元，今日环比增加9.83%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为44.44%，平均涨幅为0.81%。该股近5个交易日下跌1.90%，主力资金累计净流出2784万元；近20日主力资金累计净流入15万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408061524179f12fc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408061524179f12fc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0209","BK0187","BK0020","BK0099","BK0028","BK0183","601607","BK0012","BK0097","BK0188","BK0184","BK0175"],"gpt_icon":0},{"id":"2457903054","title":"近日《财富》杂志公布了2024年世界500强企业榜单133家中国公司上榜。其中总部位于上海的拼多多首次上榜排名第442位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457903054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457903054?lang=zh_cn&edition=full","pubTime":"2024-08-06 11:38","pubTimestamp":1722915539,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PDD","600000","BK0277","601607","LU0052750758.USD","LU0047713382.USD","BK0099","BK4501","BK4503","HK0000320264.USD","LU0320764599.SGD","BK0086","600606","HK0000306701.USD","LU0359201612.USD","LU0823038988.USD","LU0329678337.USD","BK0264","IE00B3M56506.USD","LU0516423091.SGD","LU0370786039.SGD","BK0196","BK4558","LU0594300179.USD","LU0572944931.SGD","600170","BK0188","LU0821914370.USD","HK0000306685.HKD","601328","BK4526","BK0020","LU0140636845.USD","LU0048580855.USD","CPIC.UK","LU0588546209.SGD","BK0017","600104","BK0164","L","02607","03328","BK0015","LU0359201885.HKD","600150","BK0000","LU0329678170.USD","LU0348805143.USD","LU0072462343.USD","LU0516422366.SGD"],"gpt_icon":0},{"id":"2457749367","title":"【港股通】上海医药(02607)子公司研发的甲钴胺片通过国家药监局仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2457749367","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457749367?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:06","pubTimestamp":1722848760,"startTime":"0","endTime":"0","summary":"金吾财讯 | 上海医药(02607)公布，控股子公司上海新亚药业闵行有限公司，收到国家药品监督管理局颁发的关于甲钴胺片的《药品补充申请批准通知书》(通知书编号：2024B03245)，该药品通过仿制药一致性评价。据悉甲钴胺片主要用于周围神经病，由日本卫材研发，最早于1981年在日本上市。2022年11月，新亚闵行就该药品仿制药一致性评价向国家药监局提出申请并获受理。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/OWQwNTk1YTkxMThhNDViMzhlZTk4MmY1MjNjNTJjMTgxNDI5NTA5OTg3NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWQwNTk1YTkxMThhNDViMzhlZTk4MmY1MjNjNTJjMTgxNDI5NTA5OTg3NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941688","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0187","BK0175","BK0188","BK1197","BK0209","BK0184","BK0196","BK0012","BK0028","HSTECH","02607","HSCEI","YANG","BK0097","BK0020","601607","BK0183","BK0099"],"gpt_icon":1},{"id":"2457468317","title":"上海医药(02607.HK)子公司甲钴胺片通过内地仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2457468317","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457468317?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:53","pubTimestamp":1722847980,"startTime":"0","endTime":"0","summary":"上海医药公布，其控股子公司新亚闵行近日收到国家药监局颁发的关于甲钴胺片的《药品补充申请批准通知书》，该药品通过仿制药一致性评价。甲钴胺片主要用于周围神经病，由日本卫材研发，最早于1981年在日本上市。截至目前，公司针对该药品的一致性评价已投入研发费用约403万元人民币。此外，集团指因工作调动，张耀华辞去副总裁等全部职务，自今日起生效。沽空资料截至 2024-08-05 16:25。) (A股报价延迟最少十五分钟。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210429113036647_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210429113036647_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1368973/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02607","BK0209","BK1197","BK0184","BK0012","BK0020","BK0188","BK0196","BK0097","BK0175","601607","BK0183","BK0187","BK0099","BK0028"],"gpt_icon":0},{"id":"2457745821","title":"上海医药(02607)：张耀华辞任副总裁等全部职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2457745821","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457745821?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:48","pubTimestamp":1722847685,"startTime":"0","endTime":"0","summary":"上海医药(02607)发布公告，2024年8月5日，公司董事会收到张耀华的书面辞职...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_41.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1159988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0183","BK0028","BK0175","BK0099","BK0188","BK0020","BK0184","02607","BK0097","BK0187","BK0209","BK1197","BK0012","BK0196","601607"],"gpt_icon":0},{"id":"2457745512","title":"【上海医药(02607.HK)：张耀华辞任副总裁等全部职务】智通财经APP讯，上海医药(02607.HK)发布公告，2024年8月5日，公司董事会收到张耀华的书面辞职报告。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457745512","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457745512?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:48","pubTimestamp":1722847685,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02607","BK0209","BK1197","BK0184","BK0012","BK0020","BK0188","BK0196","BK0097","BK0175","601607","BK0183","BK0187","BK0099","BK0028"],"gpt_icon":0},{"id":"2457743027","title":"【上海医药(02607.HK)：甲钴胺片通过仿制药一致性评价】智通财经APP讯，上海医药(02607.HK)发布公告，近日，上海医药控股子公司上海新亚药业闵行有限公司(以下简称“新亚闵行”)收到国家药品监督管理局(以下简称“国家药监局”)颁发的关于甲钴胺片(以下简称“该药品”)的《药品补充申请批准通知书》(通知书编号：2024B03245)，该药品通过仿制药一致性评价。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457743027","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457743027?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:46","pubTimestamp":1722847592,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0012","BK0099","02607","BK0020","BK0097","BK0183","BK0209","601607","BK0028","BK0188","BK0184","BK0175","BK0196","BK0187","BK1197"],"gpt_icon":0},{"id":"2457430707","title":"上海医药(02607)：甲钴胺片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2457430707","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457430707?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:46","pubTimestamp":1722847592,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药 发布公告，近日，上海医药控股子公司上海新亚药业闵行有限公司收到国家药品监督管理局颁发的关于甲钴胺片的《药品补充申请批准通知书》，该药品通过仿制药一致性评价。2022年11月，新亚闵行就该药品仿制药一致性评价向国家药监局提出申请并获受理。截至本公告日，公司针对该药品的一致性评价已投入研发费用约人民币403万元。IQVIA数据库显示，2023年该药品医院采购金额为人民币59702万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1159984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0020","BK0099","BK1197","BK0184","BK0183","BK0097","BK0187","BK0188","601607","BK0196","BK0028","02607","BK0175","BK0209"],"gpt_icon":0},{"id":"2457743300","title":"上海医药最新公告：副总裁张耀华先生辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2457743300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457743300?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:33","pubTimestamp":1722846791,"startTime":"0","endTime":"0","summary":"上海医药公告，公司董事会于2024年8月5日收到副总裁张耀华先生的书面辞职报告。因工作调动，张耀华先生辞去公司副总裁等全部职务，辞职报告自送达公司董事会之日起生效。辞任后，张耀华先生将不再担任公司及下属企业任何职务。张耀华先生已确认与公司及公司董事会并无任何意见分歧，亦无其他因离任而需要提请公司股东注意之事项。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500020778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0097","BK0184","BK0020","BK0028","BK0099","BK0187","BK1197","BK0188","BK0196","BK0183","BK0209","601607","BK0175","02607"],"gpt_icon":0},{"id":"2457712894","title":"上海医药(601607.SH)：甲钴胺片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2457712894","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457712894?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:33","pubTimestamp":1722843202,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司控股子公司上海新亚药业闵行有限公司(简称“新亚闵行”)收到国家药品监督管理局颁发的关于甲钴胺片的《药品补充申请批准通知书》(通知书编号：2024B03245)，该药品通过仿制药一致性评价。甲钴胺片主要用于周围神经病，由日本卫材研发，最早于1981年在日本上市。2022年11月，新亚闵行就该药品仿制药一致性评价向国家药监局提出申请并获受理。截至公告日，公司针对该药品的一致性评价已投入研发费用约人民币403万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805153511957e4798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805153511957e4798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0020","BK0196","BK0175","BK0012","BK0183","BK0097","BK0028","BK0187","BK0188","BK0209","BK0184","BK0099","601607"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1994-03-24","address":"上海市浦东新区中国(上海)自由贸易试验区张江路92号","stockEarnings":[{"period":"1week","weight":0.015},{"period":"1month","weight":0.0382},{"period":"3month","weight":0.0843},{"period":"6month","weight":0.1373},{"period":"1year","weight":0.0197},{"period":"ytd","weight":0.1964}],"companyName":"上海医药集团股份有限公司","boardCode":"AI0052","perCapita":"23817股","boardName":"零售业","registeredCapital":"370407万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":"　　上海医药集团股份有限公司主营业务为医药研发与制造、分销与零售。主要产品为丹参酮ⅡA磺酸钠注射液、注射用乌司他丁、硫酸羟氯喹片、注射用二丁酰环磷腺苷钙、注射用盐酸头孢替安、丹参片、参麦注射液、瓜蒌皮注射液、尪痹片、银杏酮酯等。集团在证券之星、第一财经以及上海市股份公司联合会共举办的\"上海上市公司评选\"中荣获\"最佳转型奖\"。中国医药上市公司竞争力50强榜首,中国医药行业\"十大最具影响力企业\"之一,\"投资者关系管理百强\";荣列上海企业100强第19位、上海制造业企业50强第9位、中国企业500强第203位、中国制造业企业500强第99位、中国制药工业百强第3位等。","serverTime":1723783748175,"listedPrice":4.5,"stockholders":"81129人(较上一季度增加Infinity%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(601607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(601607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,601607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(601607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(601607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}